GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OTCPK:EKTAY) » Definitions » Altman Z2-Score

Elekta AB (Elekta AB) Altman Z2-Score : 1.26 (As of May. 19, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Elekta AB Altman Z2-Score?

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Elekta AB has a Altman Z2-Score of 1.26, indicating it is in Grey Zones. This implies that Elekta AB is in some kind of financial stress. If it is below 1.1, the company may face bankrupcy risk.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Elekta AB's Altman Z2-Score or its related term are showing as below:

EKTAY' s Altman Z2-Score Range Over the Past 10 Years
Min: 0.8   Med: 1.62   Max: 3.48
Current: 1.27

During the past 13 years, Elekta AB's highest Altman Z2-Score was 3.48. The lowest was 0.80. And the median was 1.62.


Elekta AB Altman Z2-Score Historical Data

The historical data trend for Elekta AB's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB Altman Z2-Score Chart

Elekta AB Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.01 2.47 2.24 2.15 1.97

Elekta AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 1.97 1.22 1.16 1.27

Competitive Comparison of Elekta AB's Altman Z2-Score

For the Medical Instruments & Supplies subindustry, Elekta AB's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elekta AB's Altman Z2-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Elekta AB's Altman Z2-Score falls into.



Elekta AB Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Elekta AB's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.04+3.26*0+6.72*0.0705+1.05*0.5004
=1.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Jan. 2024:
Total Assets was $2,967 Mil.
Total Current Assets was $1,371 Mil.
Total Current Liabilities was $1,252 Mil.
Retained Earnings was $0 Mil.
Pre-Tax Income was 37.84 + 40.087 + 29.047 + 66.484 = $173 Mil.
Interest Expense was -8.977 + -7.528 + -10.19 + -9.084 = $-36 Mil.
Total Liabilities was $1,977 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(1370.749 - 1252.208)/2966.513
=0.04

X2=Retained Earnings/Total Assets
=0/2966.513
=0

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(173.458 - -35.779)/2966.513
=0.0705

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(989.159 - 0)/1976.871
=0.5004

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Elekta AB has a Altman Z2-Score of 1.26 indicating it is in Grey Zones.


Elekta AB  (OTCPK:EKTAY) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Elekta AB Altman Z2-Score Related Terms

Thank you for viewing the detailed overview of Elekta AB's Altman Z2-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Elekta AB (Elekta AB) Business Description

Address
Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.

Elekta AB (Elekta AB) Headlines

From GuruFocus

Year-end report, May-April 2020/21

By PRNewswire PRNewswire 05-28-2021

Invitation to the presentation of Elekta's fiscal year 2020/21

By PRNewswire PRNewswire 05-10-2021

Elekta wins lawsuit against Livian GmbH

By PRNewswire PRNewswire 03-08-2021

Notice to the Annual General Meeting of Elekta AB (publ)

By PRNewswire PRNewswire 07-21-2021

Elekta divests its stake in ViewRay

By PRNewswire PRNewswire 01-22-2021